Novo Holdings silent on insider trading case

A representative for the Novo Nordisk owner has refused to say whether the company received insider trading information about Convatec from the company’s former chairman, who has been fined for his involvement.

ALK's tablet trial in Ukraine set to continue

Despite the conflict between Russia and Ukraine, the allergy firm has ongoing pediatric trials in both countries. CEO Carsten Hellmann was initially surprised that this was possible in a warzone.

Latest news

See all jobs